Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Pharmaceuticals

    Pharmaceuticals - Page 79

    Aurobindo Pharma Unit-7 documents inaccurate, misleading: USFDA

    Aurobindo Pharma Unit-7 documents inaccurate, misleading: USFDA

    Medical Dialogues Bureau11 Oct 2019 10:00 AM IST
    "The responsibilities and procedures applicable to the quality control unit are not fully followed. Several lists of documents requested were either...
    Biocon arm signs licensing agreement with Evotec for biosimilar asset

    Biocon arm signs licensing agreement with Evotec for biosimilar asset

    Medical Dialogues Bureau11 Oct 2019 9:45 AM IST
    Through this in-licensing deal, Biocon Biologics has expanded its current therapeutic basket of biosimilars going beyond diabetes, oncology and...
    Sun Pharma ILUMYA phase 3 trial shows significant skin clearance in people with Plaque Psoriasis

    Sun Pharma ILUMYA phase 3 trial shows significant skin clearance in people with Plaque Psoriasis

    Farhat Nasim11 Oct 2019 9:30 AM IST
    New Delhi: Sun Pharmaceutical Industries Ltd. recently announced that one of its wholly-owned subsidiaries presented long-term follow-up data from...
    Bayer inks deals with 11 startups under G4A to develop new digital health solutions

    Bayer inks deals with 11 startups under G4A to develop new digital health solutions

    Farhat Nasim11 Oct 2019 9:25 AM IST
    New Delhi: Bayer announced recently that the company has signed collaboration agreements with eleven digital health startups. As part of the program,...
    Torrent Pharma shares slump 3pc on USFDA warning letter for Gujarat facility

    Torrent Pharma shares slump 3pc on USFDA warning letter for Gujarat facility

    Medical Dialogues Bureau11 Oct 2019 9:15 AM IST
    Torrent Pharma does not believe that the warning letter will have an impact on the disruption of supplies or the existing revenues from operations of...
    Dr Reddys Chairman Satish Reddy named as New President of Indian Pharmaceutical Alliance

    Dr Reddys Chairman Satish Reddy named as New President of Indian Pharmaceutical Alliance

    Farhat Nasim10 Oct 2019 5:01 PM IST
    Dr Reddy's Labs' Chairman, Satish Reddy played a key role in shaping policies concerning the pharmaceutical sector as well as the economy, such as...
    Aurobindo Pharma rises 5 pc post clarification on USFDA observations for Unit-7

    Aurobindo Pharma rises 5 pc post clarification on USFDA observations for Unit-7

    Medical Dialogues Bureau10 Oct 2019 11:56 AM IST
    A clarification was sought from Aurobindo Pharma regarding declining share prices on the back of USFDA observations.New Delhi: Shares of Aurobindo...
    Torrent Pharma Indrad facility gets USFDA warning letter

    Torrent Pharma Indrad facility gets USFDA warning letter

    Medical Dialogues Bureau10 Oct 2019 11:44 AM IST
    This action by the United States Food and Drug Administration (USFDA) follows earlier intimation received from the regulator in August 2019, wherein...
    Zydus Cadila gets USFDA nod for Colesevelam Hydrochloride tablets for lowering cholesterol

    Zydus Cadila gets USFDA nod for Colesevelam Hydrochloride tablets for lowering cholesterol

    Medical Dialogues Bureau10 Oct 2019 11:34 AM IST
    Zydus Cadila has received the final approval from the United States Food and Drug Administration (USFDA) to market Colesevelam Hydrochloride tablets,...
    Lupin Mandideep facility gets GMP certificate from Japanese agency PMDA

    Lupin Mandideep facility gets GMP certificate from Japanese agency PMDA

    Farhat Nasim10 Oct 2019 9:45 AM IST
    Pharmaceutical and Medical Devices Agency (PMDA) inspection closed with no critical or major observations. The GMP Certificate issued by the Japanese...
    Galderma wins USFDA nod for AKLIEF Cream to treat acne

    Galderma wins USFDA nod for AKLIEF Cream to treat acne

    Medical Dialogues Bureau10 Oct 2019 9:30 AM IST
    New Delhi: Galderma, announced recently that the U.S. Food and Drug Administration (USFDA) has approved AKLIEF (trifarotene) Cream, 0.005% for the...
    Johnson and Johnson hit with whooping USD 8 billion verdict over antipsychotic drug Risperda

    Johnson and Johnson hit with whooping USD 8 billion verdict over antipsychotic drug Risperda

    Medical Dialogues Bureau9 Oct 2019 4:24 PM IST
    Johnson and Johnson said the award was "grossly disproportionate with the initial compensatory award in this case, and the company is confident it...
    PrevNext

    Popular Stories

    Mediclaim cannot be denied on presumption of pre-existing disease: NCDRC

    Mediclaim cannot be denied on presumption of pre-existing disease: NCDRC

    Defeat Cancer, Both Physically and Financially

    Defeat Cancer, Both Physically and Financially

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Coronavirus: Restrictions imposed on the export of medical equipment to China

    Coronavirus: Restrictions imposed on the export of medical equipment to China

    Patanjali group eyes to be Rs 40,000-crore company in 2020-21

    Patanjali group eyes to be Rs 40,000-crore company in 2020-21

    Cyient gets nod to manufacture assemblies for COVID-19 diagnosis units, X-ray system

    Cyient gets nod to manufacture assemblies for COVID-19 diagnosis units, X-ray system

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok